Role of Glutathione in Cancer: From Mechanisms to Therapies
Open accessThe DOI matches its Crossref record; 177 of the 179 references it cites were found in a registry or an index.
Abstract
Glutathione (GSH) is the most abundant non-protein thiol present at millimolar concentrations in mammalian tissues. As an important intracellular antioxidant, it acts as a regulator of cellular redox state protecting cells from damage caused by lipid peroxides, reactive oxygen and nitrogen species, and xenobiotics. Recent studies have highlighted the importance of GSH in key signal transduction reactions as a controller of cell differentiation, proliferation, apoptosis, ferroptosis and immune function. Molecular changes in the GSH antioxidant system and disturbances in GSH homeostasis have been implicated in tumor initiation, progression, and treatment response. Hence, GSH has both protective and pathogenic roles. Although in healthy cells it is crucial for the removal and detoxification of carcinogens, elevated GSH levels in tumor cells are associated with tumor progression and increased resistance to chemotherapeutic drugs. Recently, several novel therapies have been developed to target the GSH antioxidant system in tumors as a means for increased response and decreased drug resistance. In this comprehensive review we explore mechanisms of GSH functionalities and different therapeutic approaches that either target GSH directly, indirectly or use GSH-based prodrugs. Consideration is also given to the computational methods used to describe GSH related processes for in silico testing of treatment effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Glutathione has a number of critical roles in healthy and tumor cells, in both cases supporting cell metabolism and survival. Several glutathione functionalities are directly or indirectly regulated by oncogenes (icons based on database [50]). Refer to text for further details.](https://figures.cochat.ai/paper-figures/2d404abae89748689c9cb3c19e9fd442/role-of-glutathione-in-cancer-from-mechanisms-to-therapies-figure-4.jpg)

![Figure 6 Relative GSH and GSSG concentrations vary slightly across cancer cell lines (data presented by Li et al., [65] and obtained from https://portals.broadinstitute.org/ccle). Figure shows concentration of GSSG as a function of the concentration of GSH in the same cell line (concentrations shown in mM). Insert plot shows differences in the ratio of GSH/GSSG across 928 cell lines.](https://figures.cochat.ai/paper-figures/6fff8e4943464a249286415d7f1c507d/role-of-glutathione-in-cancer-from-mechanisms-to-therapies-figure-6.jpg)
![Figure 7 Induction of metabolic reprogramming in recipient cells by internalization of producer cell-derived exosomes. Producer cells (e.g., cancer-associated fibroblasts) contain high levels of tricarboxylic acid (TCA) cycle metabolites, amino acids and lipids that can fuel the metabolic activity of recipient tumor cells contributing to tumor progression. Producer cells (e.g., glioma cells) derived exosomes can also harbor mRNA encoding ribosomal, oxidative phosphorylation and glycolytic proteins that can reprogram glycolysis and oxidative phosphorylation in recipient cells resulting in oncogenic reprogramming and transformation. Intraexosomal cargoes, such as metabolites, amino acids and mRNA are based on the studies of Cuperlovic-Culf et al., [156] Zhao et al., [149] and Zheng et al., [150]. EV, extracellular vesicles, such as exosomes; MVB, multivesicular body; OXPHOS, oxidative phosphorylation. Refer to text for more details.](https://figures.cochat.ai/paper-figures/dc3a5462e10e4f198bbce754fbce7225/role-of-glutathione-in-cancer-from-mechanisms-to-therapies-figure-7.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713 · cited 2×
“It has emerged as a central regulator of a recently discovered form of cell death known as ferroptosis which is induced by cytosolic and lipid ROS [83].”
BackgroundBiogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
Colombo, M., Raposo, G., & Théry, C. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101512-122326 · Cited by 6,186
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
Sies, H., & Jones, D. P. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0230-3 · Cited by 5,335 · cited 15×
“The itochondrial inner membrane nicotinamide nucleotide transhydrogenase (NNT) also produces NADPH and this serves to couple reductive stress-induced H2O2 production to NT-associated NADPH and glutathione redox mechanisms [17].”
BackgroundInfluentialTumour exosome integrins determine organotropic metastasis
Hoshino, A., Costa-Silva, B., Shen, T.-L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., Molina, H., Kohsaka, S., Di Giannatale, A., Ceder, S., et al. (2015) · Nature · doi:10.1038/nature15756 · Cited by 5,101
Chronic inflammation in the etiology of disease across the life span
Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., Ferrucci, L., Gilroy, D. W., Fasano, A., Miller, G. W., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0675-0 · Cited by 4,915 · cited 1×
“Chronic infection, injury and inflammation have long been recognized as risk factors for the development and progression of various human cancers [101].”
BackgroundFerroptosis: past, present and future
Li, J., Cao, F., Yin, H.-L., Huang, Z.-J., Lin, Z.-T., Mao, N., Sun, B., & Wang, G. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2298-2 · Cited by 4,171
Oxidative stress, aging, and diseases
Liguori, I., Russo, G., Curcio, F., Bulli, G., Aran, L., Della-Morte, D., Gargiulo, G., Testa, G., Cacciatore, F., Bonaduce, D., et al. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s158513 · Cited by 3,979 · cited 1×
“This pathway is of particular relevance to disease as oxidative stress is a hallmark of many cancers, neurodegenerative disease, and more; one result of this stress being lipid oxidation [81].”
BackgroundInflammation and cancer: triggers, mechanisms, and consequences
Greten, F. R., & Grivennikov, S. I. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.025 · Cited by 3,806 · cited 2×
“A detailed review of many roles of the inflammation-driven changes in tumorigenesis has been recently provided [102].”
BackgroundMelanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
Peinado, H., Alečković, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., García-Santos, G., Ghajar, C. M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2753 · Cited by 3,715
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579 · cited 1×
“Indeed the upregulation of NRF2 (nuclear factor, erythroid-derived 2-like 2 factor) has been observed in a wide array of tumors including breast, ovarian, prostate, skin, lung and pancreas [32,44].”
Background
Cited by
Items 201–300 of 916
Smart Modification on Magnetic Nanoparticles Dramatically Enhances Their Therapeutic Properties
Lafuente‐Gómez, N., Milán-Rois, P., García‐Soriano, D., Luengo, Y., Cordani, M., Iniesta, H. A., Salas, G., & Somoza, Á. (2021) · Cancers · doi:10.3390/cancers13164095 · Cited by 24
“Additionally, tumor tissues present higher levels of glutathione than normal tissues [22], which can be exploited to better control the GEM release at the target tissue.”
BackgroundSeshadri, V. D., Oyouni, A. A. A., Bawazir, W. M. S., Alsagaby, S. A., Alsharif, K. F., Albrakati, A., & Al‐Amer, O. M. (2022) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23146 · Cited by 22
Brindisi, M., Curcio, M., Frattaruolo, L., Cirillo, G., Leggio, A., Rago, V., Nicoletta, F. P., Cappello, A. R., & Iemma, F. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.09.157 · Cited by 22
Guo, J., Pan, Y., Chen, J., Jin, P., Tang, S., Wang, H., Su, H., Wang, Q., Chen, C., Xiong, F., et al. (2022) · Journal of Proteomics · doi:10.1016/j.jprot.2022.104741 · Cited by 22
Vitamin E and Silymarin Reduce Oxidative Tissue Damage during Gentamycin-Induced Nephrotoxicity
Georgiev, T., Nikolova, G., Dyakova, V., Karamalakova, Y. D., Georgieva, E., Ananiev, J. R., Иванов, В., & Hadzhibozheva, P. (2023) · Pharmaceuticals · doi:10.3390/ph16101365 · Cited by 24
“Via the cytochrome P450 reductase system, Fe 3+ generates • OH, thus increasing the MDA and ROS levels [24].”
BackgroundZhou, M., Yang, Z., Yin, T., Zhao, Y., Wang, C.-Y., Zhu, G., Bai, L., Jiang, Z., & Zhang, W. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c12356 · Cited by 23
Setia, A., Kumari, P., Vikas, V., Mehata, A. K., Malik, A. K., Mahto, S. K., & Muthu, M. S. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.123881 · Cited by 23
Yin, H., Liu, Y., Dong, Q., Wang, H., Yan, Y., Wang, X., Wan, X., Yuan, G., & Pan, Y. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216862 · Cited by 22
Precision Medicine in Rheumatic Diseases: Unlocking the Potential of Antibody-Drug Conjugates
Huang, Z., Braunstein, Z., Chen, J., Wei, Y., Rao, X., Dong, L., & Zhong, J. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.001084 · Cited by 24
Lin, Z., Liu, Z., Pan, Z., Zhang, Y., Yang, X., Feng, Y., Zhang, R., Zeng, W., Gong, C., & Chen, J. (2024) · Journal of Cancer · doi:10.7150/jca.95328 · Cited by 22
“When the levels of the markers associated with ferroptosis reach a certain range, the cells will undergo ferroptosis due to excess iron [22, 29].”
BackgroundWang, G., Zhang, M., Lai, W., Gao, Y., Liao, S., Ning, Q., & Tang, S. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00334 · Cited by 22
Mechanical load inhibits cancer growth in mouse and human hearts
Ciucci, G., Lorizio, D., Bartoloni, N., Budini, M., Colliva, A., Vodret, S., Nguyen, A.-V., Ciacci, L., Texler, B., Cardini, B., et al. (2026) · Science · doi:10.1126/science.ads9412 · Cited by 21
Zhu, Y., Yue, P., Dickinson, C. F., Yang, J. K., Datanagan, K., Zhai, N., Zhang, Y., Miklóssy, G., Lopez‐Tapia, F., Tius, M. A., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05477-2 · Cited by 22
de la Torre, C., Coll, C., Ultimo, A., Sancenón, F., Martínez‐Máñez, R., & Ruiz‐Hernández, E. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041071 · Cited by 21
“This concentration of GSH was chosen considering that normal intercellular GSH levels are 1–10 mM and that in tumor cells they can even increase up to 2–10 times [34,35].”
BackgroundRathnayake, K., Patel, U., Hunt, E. C., & Singh, N. (2023) · ACS Omega · doi:10.1021/acsomega.3c02901 · Cited by 21
Meng, X., Peng, X., Ouyang, W., Li, H., Na, R., Zhou, W., You, X., Li, Y., Pu, X., Zhang, K., et al. (2023) · Biological Procedures Online · doi:10.1186/s12575-023-00222-1 · Cited by 21
“Intracellular reduced glutathione (GSH) is an important indicator of the cellular redox state [52].”
BackgroundJamali, F., Lan, K., Daniel, P. M., Petrecca, K., Sabri, S., & Abdulkarim, B. (2024) · Antioxidants · doi:10.3390/antiox13101201 · Cited by 24
“However, the Trx and GSH antioxidant systems protect these cells from ROS-induced damage, keeping ROS levels below the threshold of oxidative damage to maintain their redox homeostasis [9,10,15].”
Deng, X., Milligan, K., Ali‐Adeeb, R., Shreeves, P., Brolo, A. G., Lum, J. J., Andrews, J. L., & Jirasek, A. I. (2021) · Applied Spectroscopy · doi:10.1177/00037028211035398 · Cited by 22
“), which can implicate tumour initiation, progression, and treatment response.(38,39) Mannose is a sugar monomer carbohydrate participating in glycosylation (the reaction in which a carbohydrate is attached to a hydroxyl or other functional group).”
BackgroundRajankar, N., Kumar, A., & Gulbake, A. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107050 · Cited by 21
Jiang, X.-R., Mi, J., Wang, Y., Yin, M., Tong, Y., & Zhu, Y. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s534422 · Cited by 20
“105 This pathological overexpression has driven the development of GSH-responsive MOFs exploiting two distinct activation mechanisms: coordination-induced structural reconfiguration or redox-triggered bond cleavage.”
Shahi, N., Yadav, P. N., Chaudhary, U., Saad, M., Mahiya, K., Khan, A. A., Shafi, S., & Pokharel, Y. R. (2023) · ACS Omega · doi:10.1021/acsomega.3c03824 · Cited by 20
Metabolomics analysis reveals novel serum metabolite alterations in cancer cachexia
More, T. H., Hiller, K., Seifert, M., Illig, T., Schmidt, R., Gronauer, R., von Hahn, T., Weilert, H., & Stang, A. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1286896 · Cited by 22
The role of programmed cell death in osteosarcoma: From pathogenesis to therapy
Liu, S., Liu, C., Wang, Y., Chen, J., He, Y., Hu, K., Li, T., Yang, J., Peng, J., & Hao, L. (2024) · Cancer Medicine · doi:10.1002/cam4.7303 · Cited by 22
“48,49 Cysteine is imported into the cytosol via the System XC-(consisting of transmembrane protein complex SLC7A11 and SLC3A2) in this metabolic pathway, where it is converted into cysteine to create GSH. 50 Therefore, depletion of either GPX4, System XC-, and the GSH levels can result in ROS…”
BackgroundShu, M., Wang, J., Xu, Z., Lu, T., He, Y., Li, R., Zhong, G., Yan, Y., Zhang, Y., Chu, X., et al. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.04.016 · Cited by 23
“The GSH content in cancerous cells is essential for tumor development and drug resistance [73].”
BackgroundLu, Y., Xie, X., & Luo, L. (2024) · APOPTOSIS · doi:10.1007/s10495-024-01997-8 · Cited by 23
“Also, NK cell dysfunction in the TME was caused by oxidative stress linked to lipid peroxidation suppressing NK cell glucose metabolism [17, 64], suggesting the ferroptosis susceptibility of NK cells.”
Udutha, S., Taglang, C., Batsios, G., Gillespie, A. M., Tran, M., Ronen, S. M., ten Hoeve, J., Graeber, T. G., & Viswanath, P. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115596 · Cited by 20
“25,26 GSH is a tripeptide of glutamate, cysteine, and glycine ( γ -glutamylcysteinylglycine).”
Li, X., Yu, W., Zhang, Y., Zhao, H., Wang, J., Sun, M., Xing, D., & Wang, C. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217097 · Cited by 20
Das, R., Tamang, B., Najar, I. N., Thakur, N. N., & Mondal, K. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1158411 · Cited by 20
Pashirova, T. N., Nemtarev, A. V., Souto, E. B., & Mironov, V. F. (2023) · Russian Chemical Reviews · doi:10.59761/rcr5095 · Cited by 20
Sun, Q., Lian, J., Cheng, Z., Luo, X., Qiu, Y., Li, J., & Liu, G. (2023) · Microchemical Journal · doi:10.1016/j.microc.2023.109678 · Cited by 19
Wu, Y., Huang, C.-S., Hsieh, M., Huang, C.-M., Setiawan, S. A., Yeh, C., Kuo, K.-T., & Liu, S. (2024) · Aging · doi:10.18632/aging.205409 · Cited by 36
“When the concentration of glutathione in the body is insufficient, the activity of GPX4 is reduced and the superoxide free radicals in the body are not eliminated, which eventually induces iron-dependent cell death [40].”
BackgroundZlotnikov, I. D., Ezhov, A. A., Dobryakova, N. V., & Kudryashova, E. V. (2024) · Gels · doi:10.3390/gels10030157 · Cited by 21
“GSH is the most important antioxidant in cells [40,41].”
BackgroundLalsangpuii, F., Rokhum, S. L., Nghakliana, F., Ruatpuia, J. V. L., Tochhawng, L., Trivedi, A. K., Lalfakzuala, R., & Siama, Z. (2024) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2024.2325942 · Cited by 21
“For instance, it has been observed that cancer cells with high glutathione levels exhibit increased neoplastic transformation [37], drug resistance, and cancer therapy failure [38].”
Cheng, G., Tao, S., Liu, S., Wang, P., Zhang, C., Liu, J., Hao, C., Wang, S., Guo, D. M., & Xu, B. (2024) · ACS Macro Letters · doi:10.1021/acsmacrolett.4c00125 · Cited by 19
Sun, F., Chen, Y., Lam, K. W. K., Du, W., Liu, Q., Han, F., Li, D., Lam, J. W. Y., Sun, J., Kwok, R. T. K., et al. (2024) · Small · doi:10.1002/smll.202401334 · Cited by 21
Liu, Y., Wang, X., Feng, H., Li, X., Yang, R., Zhang, M., Du, Y., Liu, R., Luo, M., Li, Z., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02574-6 · Cited by 19
“The loss of GSH disrupts redox homeostasis, leading to ROS accumulation and, subsequently, cellular dysfunction and death [10].”
BackgroundBonelli, J., Ortega, E., Vigueras, G., Bosch, M., Cutillas, N., Rocas, J., Ruiz, J., & Marchán, V. (2022) · Inorganic Chemistry Frontiers · doi:10.1039/d1qi01542g · Cited by 19
Alwahsh, M., Knitsch, R., Marchan, R., Lambert, J., Hoerner, C., Zhang, X.-N., Schalke, B. C. G., Lee, D.-H., Bulut, E. L., Graeter, T. P., et al. (2022) · Cancers · doi:10.3390/cancers14061564 · Cited by 19
“Similarly, high levels of glutathione, one of the key regulators of the cellular redox state, are also typically found in a variety of aggressive cancers and associated with tumor progression and increased resistance to chemotherapy [52].”
BackgroundStimulus-responsive inorganic semiconductor nanomaterials for tumor-specific theranostics
Hu, X., Ha, E., Ai, F., Huang, X., Yan, L., He, S., Ruan, S., & Hu, J. (2022) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2022.214821 · Cited by 20
Nanotherapy based on magneto‐mechanochemical modulation of tumor redox state
Orel, V. B., Papazoglou, Α. S., Tsagkaris, C., Moysidis, D. V., Papadakos, S. P., Galkin, A. Y., Vé, O., & Syvak, L. A. (2022) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1868 · Cited by 19
Shi, J., Cui, G., Jin, Y., Mi, B., Liu, K., Zhao, L., Bao, K., Lu, Z., Liu, J., Wang, Y., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202402474 · Cited by 18
Zhou, B., Li, J., Wu, A., Wang, X., Cheng, L., Yang, G., Gao, D., & Zhu, C. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1587986 · Cited by 18
“…tripeptide containing a γ -acyl amide bond and a thiol group, synthesized from Glu, Cys, and glycine(Gly), retaining the reducing thiol group of Cys, which gives GSH certain reducing properties and plays an important role in antioxidant defense (Kennedy et al., 2020; Lin et al., 2024).”
Wang, X., Zhou, P., Zhang, Z., Huang, Q., Chen, X., Ji, L., Cheng, X., Shi, Y., Yu, S., Tang, J., et al. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.09.002 · Cited by 18
Lopez‐Sanchez, A., & Bertrand, H. C. (2024) · Inorganic Chemistry Frontiers · doi:10.1039/d3qi02602g · Cited by 19
Wang, M., Deng, D., Zhou, A.-M., Su, Y., Yu, Z., Liu, H. K., & Su, Z. G. (2024) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.4c00060 · Cited by 18
Zhang, X., Zhao, B., Fu, S., Seruya, R. S., Madey, J. F., Bukhryakova, E., & Zhang, F. (2024) · Macromolecules · doi:10.1021/acs.macromol.3c02633 · Cited by 18
Abeesh, P., & Guruvayoorappan, C. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102832 · Cited by 18
Yang, J.-I., Lee, H. L., Yun, J.-J., Kim, J., So, K.-H., Jeong, Y., & Kang, D.-H. (2022) · Materials · doi:10.3390/ma15113795 · Cited by 19
“The elevated levels of GSH in tumor tissues are frequently associated with drug-resistance problems [34].”
BackgroundAdvances on Delivery of Cytotoxic Enzymes as Anticancer Agents
Asrorov, A. M., Muhitdinov, B. I., Tu, B., Mirzaakhmedov, S. Y., Wang, H., & Huang, Y. (2022) · Molecules · doi:10.3390/molecules27123836 · Cited by 18
“Recently, novel approaches have been developed to target glutathione-linked antioxidative pathways in cancer cells, which include DNA synthesis/repair, antioxidant defense, protein synthesis, and cell division and proliferation, as well as post-translational modifications or ferroptosis [82].”
BackgroundIntersection of ferroptosis and nanomaterials brings benefits to breast cancer
Gao, J., Ma, N., Ni, S., & Han, X. F. (2025) · Cell Biology and Toxicology · doi:10.1007/s10565-025-10067-x · Cited by 17
“High GSH levels in tumor cells are associated with tumor progression and chemoresistance (Kennedy, et al. 2020).”
Hydrogels—Advanced Polymer Platforms for Drug Delivery
(Vatcu), R. E., Iacob, A.-T., Fulga, I., Gioia, M. L. D., Dragostin, I., Fulga, A., Samal, S. K., & Dragostin, O.-M. (2026) · Polymers · doi:10.3390/polym18060709 · Cited by 23
Wang, D., & Zhang, J. (2023) · Rare Metals · doi:10.1007/s12598-023-02450-6 · Cited by 17
“The tumor microenvironment contained a large amount of glutathione (GSH) which could neutralize the ROS produced by SDT [72, 73].”
Photocatalysis-promoted tumor ferroptosis enabled by MOF-derived black TiO2
Zhuang, H., Wang, L., Shao, S., Jing, H., Xue, P., Bai, T., Deng, J., Zeng, X., Qin, X., & Yan, S. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.154204 · Cited by 17
Stimuli-responsive prodrugs with self-immolative linker for improved cancer therapy
Wenting, X., Jia, A., Lei, Z., Wang, J., Jiang, H., Wang, S., & Wang, Q. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116928 · Cited by 17
Cascade-enhanced based-polyoxometalates nanozyme for glutathione detection and tumor cell disruption
Guo, J., Han, H., Zhao, H. L., Jia, D., Yin, L., & Sha, J. (2025) · Talanta · doi:10.1016/j.talanta.2025.127890 · Cited by 17
Zhou, M., Huang, Z., Ma, Z., Chen, J., Lin, S., Yang, X., Gong, Q., Braunstein, Z., Wei, Y., Rao, X., et al. (2025) · Cancer Drug Resistance · doi:10.20517/cdr.2025.49 · Cited by 43
El-Batal, A. I., Ragab, Y. M., Amin, M. A., El-Roubi, G. M., & Mosallam, F. M. (2021) · BioMetals · doi:10.1007/s10534-021-00309-w · Cited by 17
“…and anti-inflammatory retort as an antioxidant ROS scavenger in the oxidative stress as well as signaling molecule that regulates protein function through thiol– disulfide exchange reactions such as protein glutathionylation with many examples of regulation of oncogenes (Kennedy et al. 2020).”
BackgroundComparing the Secretomes of Chemorefractory and Chemoresistant Ovarian Cancer Cell Populations
Lee, A. H., Peña, C. M., & Dawson, M. (2022) · Cancers · doi:10.3390/cancers14061418 · Cited by 18
Gastric Cancer Pre-Stage Detection and Early Diagnosis of Gastritis Using Serum Protein Signatures
Aziz, S., Rasheed, F., Zahra, R., & König, S. (2022) · Molecules · doi:10.3390/molecules27092857 · Cited by 19
“As the string networks of the upregulated proteins in MiGn and MiGa (Supplementary Figures S61 and S62) show, albumin/apolipoproteincentered interactions in MiGn lose importance in MiGa and give way to, among others, members of the glutathione antioxidant system (glutathione S-transferase theta-1 (GSTT1), glutathione…”
BackgroundCastro, F. D., Stefàno, E., Luca, E. D., Muscella, A., Marsigliante, S., Benedetti, M., & Fanizzi, F. P. (2022) · Bioinorganic Chemistry and Applications · doi:10.1155/2022/8932137 · Cited by 17
“Indeed, recently, several novel therapies have been developed to target the GSH antioxidant system in tumors as a means for increased response and decreased drug resistance [36].”
BackgroundRewired Metabolism of Amino Acids and Its Roles in Glioma Pathology
Chen, S., Jiang, J., Shen, A., Miao, Y., Cao, Y., Zhang, Y., Cong, P., & Gao, P. (2022) · Metabolites · doi:10.3390/metabo12100918 · Cited by 18
“The consumed glycine was either converted to one-carbon units to support purine synthesis or incorporated into glutathione (GSH) to clear reactive oxygen species (ROS) [30,31].”
BackgroundInfluentialELK1 / KIFC1 axis promotes breast cancer cell proliferation by regulating glutathione metabolism
Yang, B., Wang, H., Jian, X., Chen, W., & Chen, W. (2023) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15710 · Cited by 17
“Besides, previous studies have pointed out the association between the GSH metabolic pathway and occurrence of tumors.(29) In this way, it was reasonable to hypothesize that KIFC1 might promote BC cell proliferation by regulating GSH metabolism.”
BackgroundSun, F., Wang, T., Wang, P., Shi, J., Shen, Y., Wang, G., Yang, B., Li, H., Zhang, Q., Chen, Y., et al. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c11564 · Cited by 18
Wu, M., Gong, D., Zhou, Y., Zha, Z., & Xia, X. (2023) · Journal of Materials Chemistry B · doi:10.1039/d3tb01590d · Cited by 18
XA4C: eXplainable representation learning via Autoencoders revealing Critical genes
Li, Q., Yu, Y., Kossinna, P., Lun, T., Liao, W., & Zhang, Q. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011476 · Cited by 16
“However, GSH metabolism can also play a pathogenic role 179 in cancer by conferring therapeutic resistance and promoting tumor progression [30, 31].”
BackgroundChen, B., Dong, X., Zhang, J., Wang, W., Song, Y., Sun, X., Zhao, K., & Sun, Z. (2023) · Medicine · doi:10.1097/md.0000000000036157 · Cited by 17
“[17,18] As an important antioxidant in cells, GSH mediates the regulation of target signaling molecule expression to maintain redox homeostasis and protect host cells from damage including damage caused by lipid peroxidation.”
BackgroundJia, T., Nie, P., & Xu, H. (2024) · Environmental Toxicology · doi:10.1002/tox.24141 · Cited by 18
“…sulfhydryl groups, which can directly reduce FR to acids, thereby accelerating their excretion and counteracting injury to vital organs by FR. 59 A decrease in SOD, CAT, and GSH could lead to an increase in FR. Free radicals induce lipid peroxidation in the body and MDA is one of the end…”
BackgroundLi, Z., Lu, J., Dong, Z., Liang, J., Li, S., Han, W., Cui, T., & Liu, H. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03644-0 · Cited by 17
“Several studies have shown that GSH has a dual regulatory effect on ferroptosis [15, 16].”
BackgroundA redox-responsive prodrug for tumor-targeted glutamine restriction
Prange, C. J., Sayed, N. Y. B., Feng, B., Goepfert, C., Ortiz, D., Hu, X., & Tang, L. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.02.031 · Cited by 19
The new era of lung cancer therapy: Combining immunotherapy with ferroptosis
Li, Y., Tuerxun, H., Zhao, Y., Liu, X., Li, X., Wen, S., & Zhao, Y. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104359 · Cited by 17
Wang, Q., Zhang, W., Cai, M., Ma, Y., Yu, A., Chen, S., & Zhang, S. (2024) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2024.136151 · Cited by 16
Nanozyme-based synergistic therapeutic strategies against tumors
Zhang, Y., Zhang, N., Gong, S., Chen, Z., & Cao, H. (2025) · Drug Discovery Today · doi:10.1016/j.drudis.2025.104292 · Cited by 16
Varlamova, E. G. (2025) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2025.110344 · Cited by 16
Ibrahim, N. S., Shoukry, E. H., Sharaky, M. M., Diab, H. M., Elwahy, A. H. M., & Abdelhamid, I. A. (2025) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2025.111549 · Cited by 16
Semreen, A. M., Alsoud, L. O., El‐Huneidi, W., Ahmed, M., Bustanji, Y. K., Abu‐Gharbieh, E., El‐Awady, R., Ramadan, W. S. H., Alqudah, M. A. Y., Shara, M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213940 · Cited by 16
“High ROS and consequent disruptions in GSH homeostasis are hallmarks of cancer cells [30,31].”
BackgroundWang, J., Zhao, J., Ma, F., Gong, L., Lu, Y., Xiao, W., Tang, H., Gao, C., Chen, Y., Ma, J., et al. (2022) · Small · doi:10.1002/smll.202204238 · Cited by 16
Zachou, M.-E., Spyratou, E., Lаgopati, N., Platoni, K., & EFSTATHOPOULOS, E. P. (2025) · Cancers · doi:10.3390/cancers17142295 · Cited by 17
“Glutathione is an important antioxidant that prevents damage caused by ROS to the DNA and other important components of the cells [78,79].”
Melatonin and Lipid Peroxidation: Antioxidant Shield and Therapeutic Potential
Volpe, O. A. J. N., Zuccari, D. A. P. D. C., Chuffa, L. G. D. A., & Reiter, R. J. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl45321 · Cited by 16
Wang, W., & Zhang, N. (2023) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgad025 · Cited by 15
Lan, T., He, S., Luo, X., Pi, Z., Lai, W., Jiang, C., Gan, J., Wei, S., Wu, Z., Yun, C., et al. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118340 · Cited by 16
The Influence of Microbiota on Breast Cancer: A Review
Neagoe, C.-X.-R., Ionică, M., Neagoe, O. C., & Trifa, A. P. (2024) · Cancers · doi:10.3390/cancers16203468 · Cited by 19
“Disruptions in glutathione metabolism are involved in tumor growth, development, progression, and therapeutic response [53,55].”
Hamed, A. M., Elbahy, D. A., Hamed, A., Thabet, S. A., Refaei, R. A., Ragab, I., Elmahdy, S. M., Osman, A., & Abouelella, A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e41043 · Cited by 16
“It is responsible for replenishing GPXs, which detoxify lipid hydroperoxides and H 2 O 2 [91].”
Cascade-Responsive Nanoparticles for Efficient CRISPR/Cas9-Based Glioblastoma Gene Therapy
Li, Q., Zhang, Z., Wu, X., Zhao, Y., & Liu, Y. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c15671 · Cited by 15
Pegoraro, C., Masiá, E., Đorđević, S., Dolz‐Pérez, I., Huck‐Iriart, C., Herrera, L., Esteban-Pérez, S., Conejos‐Sánchez, I., & Vicent, M. J. (2025) · Chemistry of Materials · doi:10.1021/acs.chemmater.4c02742 · Cited by 15
Dangi, K., Kumar, V., Mittal, D., Yadav, P., Malik, M., & Verma, A. K. (2025) · Nanomedicine · doi:10.1080/17435889.2025.2489918 · Cited by 15
The rise and evolving role of Fusobacterium nucleatum subspecies
Wolf, M., Steinberg, T., Scholz, K. J., Kruse, A., Rezasoltani, S., Conrads, G., Al‐Ahmad, A., & Cieplik, F. (2025) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2025.100414 · Cited by 24
“…probably due to the enrichment of glutathione metabolism and γ -glutamyl amino acid pathways in Fna C2-treated mice contributing to oxidative stress (driving genomic instability) and tumor progression (Hanigan, 2014; Kennedy et al., 2020; Pompella et al., 2006; Zepeda-Rivera et al., 2024).”
Ha, J. H., Jayaraman, M., Nadhan, R., Kashyap, S., Mukherjee, P., Isidoro, C., Song, Y. S., & Dhanasekaran, D. N. (2021) · Biomedicines · doi:10.3390/biomedicines9121927 · Cited by 16
“Increased levels of GSH contributes to therapy resistance by quenching therapy-induced reactive oxygen species involved in cell death [66,67].”
BackgroundPillai, V. M., Sreejaya, M. M., Ajula, C. P., Haridev, M., Murali, A., Harikrishnan, K., Bera, M., & Gangopadhyay, M. (2024) · Dyes and Pigments · doi:10.1016/j.dyepig.2024.112006 · Cited by 15
Liu, Y., Liu, F., Liu, J., Cairang, D., Li, X., Xia, P., Ma, W., Wu, T., Gongye, X., Zhang, Z., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-4015 · Cited by 15
Oxidative Stress in the Tumor Immune Microenvironment: Mechanisms and Therapeutic Perspectives
Wang, Z., Li, B., Tang, P., Yan, F., Wang, S., Leng, G., Dawa, P., Chen, Y., Guo, Y., Yang, P., et al. (2026) · MedComm – Oncology · doi:10.1002/mog2.70068 · Cited by 18
Babanyinah, G. K., Bhadran, A., Polara, H., Wang, H., Shah, T. V., Biewer, M. C., & Stefan, M. C. (2024) · Chemical Science · doi:10.1039/d4sc01625d · Cited by 14
Smart nanocarriers for enzyme-activated prodrug therapy
Qoura, L. A., Morozova, E. A., Ramaa, C. S., & Pokrovsky, V. S. (2024) · Journal of drug targeting · doi:10.1080/1061186x.2024.2383688 · Cited by 14
Recent advances in targeted drug delivery systems for multiple myeloma
Pant, A., Laliwala, A., Holstein, S. A., & Mohs, A. M. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.10.003 · Cited by 16
Yin, B., Chen, J., Xiang, G., Xu, Z., Yang, M., & Wong, S. H. D. (2024) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2024.117066 · Cited by 15
Targeting ncRNAs to overcome metabolic reprogramming‑mediated drug resistance in cancer (Review)
Li, J., Li, Y., Fu, L., Chen, H., Du, F., Wang, Z., Zhang, Y., Huang, Y. Y., Miao, J., & Xiao, Y. (2025) · International Journal of Oncology · doi:10.3892/ijo.2025.5741 · Cited by 16
“Mitochondria are key in metabolic reprogramming, supporting the catabo‑ lism of amino acids, nucleotides and lipids, as well as the production of NADH and NADPH (192).”
InfluentialAlbasiony, A. M., Beltagi, A. M., Ibrahim, M. M., Shaban, S. Y., & van Eldik, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136070 · Cited by 14
“This was explained by the reduction-sensitive GSH-responsive connections that were broken by the increased GSH levels in tumor cells [83].”
Vijayan, S., Loganathan, C., Sakayanathan, P., & Palvannan, T. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1959404 · Cited by 16
“antioxidants level, in particular decrease of GSH level can be considered important because tumorigenesis was suppressed when GSH was depleted (Harris et al., 2015; Kennedy et al., 1975).”
BackgroundMellinger, A. L., Garrard, K. P., Khodjaniyazova, S., Rabbani, Z. N., Gamcsik, M. P., & Muddiman, D. C. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00636 · Cited by 14
Ding, W., Yao, S., Chen, Y., Wu, Y., Li, Y., He, W., & Guo, Z. (2023) · Molecules · doi:10.3390/molecules28052229 · Cited by 14
“Additionally, targeting glutathione metabolic pathways has been extensively studied [2,11,12].”
Alapati, S., Fortuna, G., Ramage, G., & Delaney, C. (2023) · Metabolites · doi:10.3390/metabo13080890 · Cited by 17
“Glutathione, which is an antioxidant produced by our body, is responsible for this, taking part in various cellular activities such as detoxification and keeping cells in a balanced reduction-oxidation state [84].”
Background
Metadata
- Authors
- Kennedy, L., Sandhu, J. K., Harper, M.-E., & Cuperlovic-Culf, M.
- Affiliations
- University of Ottawa (CA)
- Department of Biochemistry, Microbiology and Immunology, University of Ottawa, 451 Smyth Road, Ottawa, ON K1H 8M5, Canada
- Venue
- Biomolecules
- Publisher
- MDPI AG
- Published
- 2020-10-09
- Volume
- 10
- Issue
- 10
- Pages
- 1429
- ISSN
- 2218-273X (ISSN-L)
- PMC
- PMC7600400
- OpenAlex
- W3092136373
- Cited by
- 880
- References
- 179
- Citations by year
- 2026: 140 · 2025: 197 · 2024: 201 · 2023: 159 · 2022: 123 · 2021: 58
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Biomolecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- NPARC (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Council Canada
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Sulfur Compounds in Biology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- glutathione, cancer, redox homeostasis, antioxidant defense, reactive oxygen species, reactive nitrogen species, lipid peroxidation, xenobiotic detoxification, chemoresistance, ferroptosis, apoptosis, tumor progression
- MeSH terms
- Animals, Drug Screening Assays, Antitumor, Glutathione, Homeostasis, Humans, Neoplasms, Oxidation-Reduction, Signal Transduction, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.